Protection and therapy of experimental herpesvirus infections in mice with immunomodulating Propionibacterium avidum KP-40 and/or acyclovir

Zentralblatt fur Bakteriologie

Volumn 285, Issue 3, 1997, Pages 445-449

  Kobus, M ^a   Luczak, M ^a   Sobiczewska, E ^b   Szmigielski, S ^b   Jeljaszewicz, J ^c   Pulverer, G ^d,e  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MILITARY INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Poland)

^c NATIONAL INSTITUTE OF HYGIENE   (Poland)

^d UNIVERSITY OF COLOGNE   (Germany)

^e UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031079842     PISSN: 09348840     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0934-8840(97)80011-4     Document Type: Article

References (22)

1. Adlam, C. and M. T. Scott: Lymphoreticular stimulatory properties of Corynebacterium parvum and related bacteria. J. Med. Microbiol. 6 (1973) 262-274
2. Balfour, H. H., C. Benson, J. Braun, B. Cassen, A. Erice, A. Friedman-Kien, T. Klein, B. Polsky, et al.: Management of acyclovir-resistant herpes simplex and varicella zoster virus infections. J. Acquired Immun. Def. Syndr. 7 (1994) 254-260
3. Beuth, J., H. L. Ko, K. M. Peters, B. Bornhofen, and G. Pulverer: Behaviour of lymphocyte subsets in reponse to immunotherapy with Propionibacterium avidum KP-40 in cancer patients. Zbl. Bakt. 273 (1990) 386-390
4. Catalano, L. W. and S. Baron: Protection against herpes virus and encephalomyocarditis virus encephalitis with a double stranded RNA inducer of interferon. Proc. Soc. Exp. Biol. Med. 133 (1970) 684-689
5. Collins, P. and M. N. Ellis: Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir. J. Med. Virol. 41 (Suppl. 1) (1993) 58-66
6. De Clerq, E. and M. Luczak: Intranasal challenge of mice with herpes simplex virus: experimental model for evaluating the efficacy of antiviral drugs. J. Infect. Dis. 133 (Suppl.) (1976) A226-A236
7. Greene, J. J.: Double-stranded RNA and its analogs: The prospects and the promise of the first nucleic acid therapeutic agent. In: Clinical Applications of Interferon and IFN Inducers (ed.), Strangfellow, DA pp. 245-276, Marcel Dekker, Inc., New York (1986)
8. Ikeda, S., S. Nishiya, A. Yamamoto, T. Yamase, C. Nishimura, and E. De Clerq: Activity of the Keggin polyoxotungstate MP-19 against herpes simplex virus type 2 infection in immunosuppressed mice: role of peritoneal macrophage activation. J. Med. Virol. 41 (1993) 191-195
9. Kirchner, H., H. M. Hirt, and K. Munk: Protection against herpes simplex virus infection in mice by Corynebacterium parvum. Infect. Immun. 16 (1977) 9-11
10. Kirchner, H., M. T. Scott, and K. Munk: Protection of mice against viral infections by Corynebacterium parvum and Bordetella pertussis. J. Gen. Virol. 41 (1978) 97-104
11. Ko, H. L., W. Roszkowski, J. Jeljaszewicz, and G. Pulverer: Comparative study on the immunostimulatory potency of different propionibacteria strains. Med. Microbiol. Immunol. 170 (1981) 1-9
12. Mogensen, S. C.: Role of macrophage in natural resistance to virus infections. Microbiol. Rev. 43 (1979) 1-34
13. Morahan, P. S.: Interactions of herpes viruses with mononuclear phagocytes. In: Immunobiology of Herpes Simplex Virus Infections, Rouse, B. T. and C. Lopez (eds.), pp. 71-92, CRC Press, Boca Raton, FL (1984)
14. Morahan, P. S., E. R. Kern, and L. A. Glasgow: Immunomodulator-induced resistance against herpes simplex virus. Proc. Soc. Exp. Biol. Med. 154 (1977) 615-619
15. Nyquist, A. C., H. A. Rotbart, M. Cotton, C. Robinson, and A. Weinberg: Acyclovirresistant neonatal herpes simplex virus infection of the larynx. J. Pediatrics 124 (1994) 967-971
16. Pelosi, E., K. A. Hicks, S. L. Sacks, and D. M. Coen: Heterogenicity of a herpes simplex virus clinical isolate exhibiting resistance to acyclovir and foscarnet. Adv. Exp. Med. Biol. 312 (1992) 151-158
17. Pulverer, G., H. L. Ko, W. Roszkowski, K. Roszkowski, and J. Jeljaszewicz: Immunomodulation by propionibacteria. Clin. Immunol. Newsletters 6 (1985) 51-54
18. Pyo, S., J. D. Gangemi, A. Ghaffar, and E. P. Mayer: Poly I:C-induced anti-herpes simplex virus type 1 activity in inflammatory macrophages is mediated by induction of interferon-beta. J. Leukocyte Biol. 50 (1991) 479-487
19. Roszkowski, W., K. Roszkowski, H. L. Ko, J. Beuth, and J. Jeljaszewicz: Immunomodulation by propionibacteria. Zbl. Bakt. 274 (1990) 289-298
20. Safrin, S., T. Elbeik, and J. Mills: A rapid screen test for in vitro susceptibility of clinical herpes simplex virus isolates. J. Infect. Dis. 169 (1994) 879-882
21. Szmigielski, S., M. Kobus, J. Gil, J. Jeljaszewicz, and G. Pulverer: Protection and therapy of mice with acute and chronic experimental virus infections with Propionibacterium granulosum KP-45. Zbl. Bakt. 248 (1980) 286-295
22. Szmigielski, S., M.Kobus, J. Gil, J. Jeljaszewicz, and G. Pulverer: Antineoplastic and antiviral properties of Propionibacterium granulosum. Drugs Exptl. Clin. Res. 8 (1982) 387-401